However, tumor cells often evade immune clearance and apoptotic signals through various mechanisms, such as mutations that inhibit apoptosis‐related proteins (e.g., p53) or activate antiapoptotic pathways (e.g., the Bcl‐2 family).141. This evidence concerns the gene TP53 and neoplasm.